Search company, investor...

About medimix

Headquarters Location

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo
You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.
Click Now. Join a live demo
Join a demo

Latest medimix News

Gokaldas to acquire Dubai's Atraco; Medimix owner buys Future's Nilgiri Dairy

Aug 29, 2023

Credit: 123RF.com Gokaldas Exports Ltd has agreed to acquire Dubai-based apparel manufacturer Atraco Group for an equity consideration of $55 million to expand its global presence. Gokaldas, which was previously backed by private equity giant Blackstone , said it will fund the acquisition through a mix of debt and internal accruals. The transaction will comprise of acquisition of shares and assets and will be subject to customary regulatory approvals, Gokaldas said in a stock-exchange filing. It expects to close the deal during the October-December quarter. Advertisement Atraco was founded in 1986 and is headquartered in Dubai, where it has its marketing, sourcing, product development and corporate functions. It operates four manufacturing units in Kenya and one in Ethiopia, producing about 40 million garments annually. It has more than 13,000 workers. Atraco Group reported revenue of about $107 million and a profit after tax of $7.2 million for the calendar year 2022. “We have always believed in continuously adding production capacity at strategic locations... With this acquisition, we will gain access to low-cost duty-free locations for manufacturing,” said Sivaramakrishnan Ganapathi, Vice Chairman and Managing Director of Gokaldas. Advertisement Shares of Gokaldas jumped 20% to close at a one-year high of Rs 736.30 apiece on the BSE on Tuesday. Nilgiri Dairy Farm Future Consumer Ltd said Tuesday its board decided to sell wholly owned subsidiary The Nilgiri Dairy Farm Pvt. Ltd to AVA Cholayil Healthcare Pvt. Ltd, the owner of Medimix brand, for Rs 67 crore ($8.1 million). Advertisement The deal includes the sale of Nilgiri’s franchisee operations, retail trade operations, sourcing, processing, packaging and marketing of dairy products, bakery products, fast-moving consumer goods, staples and other products. The company will get 60% of the amount at the time of closing the deal and the remaining in two equal tranches. Nilgiri recorded revenue of Rs 39.66 crore for the year ended March 31, constituting 10.40% of the consolidated turnover of Future Consumer. Advertisement

medimix Frequently Asked Questions (FAQ)

    CB Insights
    Looking for a leg up on competitive, customer and technology insights?
    CB Insights puts confidence and clarity into your most strategic decisions.
    See how. Join a demo.
    Join a demo
    Trusted by the world's smartest companies to:
    • Predict emerging trends
    • See competitors' playbooks
    • Stalk the smart money
    • Identify tomorrow's challengers
    • Spot growing industries
    • Kill analyst data work
    Let's see how we can help you!
    MicrosoftWalmartWells Fargo

    Discover the right solution for your team

    The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

    Join a demo

    CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.